Skip to main content
. 2022 Oct 10;79(12):1260–1266. doi: 10.1001/jamaneurol.2022.3285

Table 1. Patient Characteristics.

Variable No. (%) P value
ASPECTS ≤3 (n = 106) ASPECTS 4-5 (n = 96)
Age, mean (SD), y 76.7 (9.6) 75.6 (10.6) .46
Female 54 (50.9) 36 (37.5) .055
Male 52 (49.1) 60 (62.5)
Modified Rankin Scale score before onset, median (IQR) 0 (0-1) 0 (0-1) .38
Baseline NIHSS score, median (IQR) 23 (17-26) 21 (18-25) .14
Medical history
Hypertension 74 (69.8) 67 (69.8) >.99
Diabetes 24 (22.6) 19 (19.8) .62
Hyperlipidemia 30 (28.3) 19 (19.8) .16
Atrial fibrillation 64 (60.4) 55 (57.3) .66
Current smoking 18 (17.0) 21 (21.9) .38
Blood pressure, mean (SD), mm Hga
Systolic 159.5 (30.3) 159.6 (27.3) .99
Diastolic 86.4 (21.0) 89.6 (18.2) .25
Laboratory tests
Cholesterol, mean (SD), mg/dLb
LDL 110.8 (32.2) 106.5 (32.7) .39
HDL 56.7 (16.6) 56.2 (16.9) .86
Blood glucose, median (IQR), mg/Lc 138 (116-163) 129 (116-147) .16
Creatinine, median (IQR), mg/dLd 0.80 (0.66-1.08) 0.83 (0.70-1.05) .45
CRP, median (IQR), mg/dLe 0.25 (0.10-0.92) 0.13 (0.06-0.37) <.001
Internal carotid artery occlusion 55 (51.9) 40 (41.7) .15
MRI 95 (89.6) 79 (82.3) .13
ASPECTS NA
0-2 8 (7.5) 0
3 98 (92.5) 0
4 0 56 (58.3)
5 0 40 (41.7)
Infarction volume, median (IQR), mLf 126 (83-168) 89 (60-122) <.001
Intravenous rt-PA use 28 (26.4) 27 (28.1) .79
Time from onset to image, median (IQR), min 198 (103-376) 159 (101-400) .46
Time from onset to randomization, median (IQR), min 224 (140-405) 207 (145-427) .62
Time from onset to puncture, median (IQR), min 263 (170-523) 237 (165-388) .38
Time from onset to reperfusion, median (IQR), min 320 (223-559) 292 (207-479) .33
Reperfusion degree with TICI ≥2b 47/56 (83.9) 39/44 (88.6) .50
Stroke classification
Cardioembolic 84 (79.2) 75 (78.1) .87
Atherothrombotic 5 (4.7) 7 (7.3)
Cryptogenic 14 (13.2) 11 (11.5)
Other 3 (2.8) 3 (3.1)

Abbreviations: ASPECTS, Alberta Stroke Program Early Compute Tomography Score; CRP, C-reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MRI, magnetic resonance imaging; NA, not applicable; NIHSS, National Institutes of Health Stroke Scale; rt-PA, recombinant tissue plasminogen activator; TICI, thrombolysis in the cerebral infarction.

a

Data missing for 2 participants for systolic and diastolic blood pressure.

b

To convert to mmol/L, multiply by 0.0259. Data missing for 33 participants for LDL cholesterol and 34 for HDL cholesterol.

c

To convert to mmol/L, multiply by 0.0555. Data missing for 2 participants for blood glucose.

d

To convert to μmol/L, multiply by 76.25.

e

To convert to mg/L, multiply by 10.

f

Data missing for 20 participants for infarction volume.